Dr. Martens Overview

  • Year Founded
  • 1960

Year Founded

  • Status
  • Public

  • Employees
  • 2,377

Employees

  • Stock Symbol
  • DOCS

Stock Symbol

  • Investments
  • 2

  • Share Price
  • $0.68
  • (As of Friday Closing)

Dr. Martens General Information

Description

Dr. Martens PLC is engaged in the footwear business. Its product segments include Originals, Fusion, Kids and Casual, and a complementary range of Accessories. The company has sales through E-commerce, Retail, and Wholesale of Products. Geographically, it derives the majority of its revenue from EMEA and has a presence in the Americas and APAC.

Contact Information

Formerly Known As
Airwair Europe, Airwair Uk, Meaujo (261)
Ownership Status
Publicly Held
Financing Status
Formerly PE-Backed
Corporate Office
  • 28 Jamestown Road
  • Camden
  • London NW1 7BY
  • England, United Kingdom
+44 0371
Primary Industry
Footwear
Other Industries
Accessories
Stock Exchange
LON
Vertical(s)
Corporate Office
  • 28 Jamestown Road
  • Camden
  • London NW1 7BY
  • England, United Kingdom
+44 0371

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Dr. Martens Stock Performance

As of 20-Nov-2026, Dr. Martens’s stock price is $0.68. Its current market cap is $649M with 951M shares.

(As of Friday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$0.68 $0.72 $0.67 - $1.22 $649M 951M 1.66M $0.04

Dr. Martens Financials Summary

As of 30-Sep-2026, Dr. Martens has a trailing 12-month revenue of $983M.

In Thousands,
USD
TTM 30-Sep-2026 FY 2026 31-Mar-2026 FY 2025 31-Mar-2025 FY 2024 31-Mar-2024
EV 1,163,469 1,190,171 1,094,295 1,675,496
Revenue 983,187 1,024,978 1,004,425 1,102,064
EBITDA 165,853 166,162 136,074 242,879
Net Income 37,273 31,892 5,739 86,949
Total Assets 1,144,758 1,155,543 1,151,144 1,202,404
Total Debt 530,375 518,302 522,789 602,212
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Dr. Martens Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Dr. Martens‘s full profile, request access.

Request a free trial

Dr. Martens Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Dr. Martens PLC is engaged in the footwear business. Its product segments include Originals, Fusion, Kids and Casual, an
Footwear
London, United Kingdom
2,377 As of 2026

Firenze, Italy
 

Edinburgh, United Kingdom
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Dr. Martens Competitors (2)

One of Dr. Martens’s 2 competitors is Salvatore Ferragamo, a Corporate Backed or Acquired company based in Firenze, Italy.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Salvatore Ferragamo Corporate Backed or Acquired Firenze, Italy
HBL Realisations Formerly PE-Backed Edinburgh, United Kingdom
You’re viewing 2 of 2 competitors. Get the full list »

Dr. Martens Patents

Dr. Martens Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-D1141356-S1 Footwear sole Active 15-Jul-2025
US-D1132022-S1 Bag Active 27-Jun-2025
US-D1147679-S1 Footwear Active 18-Jun-2025
US-D1138146-S1 Bag Active 30-May-2025
US-D1127364-S1 Footwear Active 29-Jan-2025
To view Dr. Martens’s complete patent history, request access »

Dr. Martens Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Dr. Martens Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Dr. Martens‘s full profile, request access.

Request a free trial

Dr. Martens Investments (2)

Dr. Martens’s most recent deal was a PE Growth/Expansion with Gen Phoenix for . The deal was made on 07-Mar-2023.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Gen Phoenix 07-Mar-2023 PE Growth/Expansion Animal Textiles
Luminary Bakery 30-Oct-2019 Later Stage VC Restaurants and Bars
To view Dr. Martens’s complete investments history, request access »

Dr. Martens ESG

Risk Overview

Risk Rating

Updated November, 17, 2026

18.31 | Low Risk

Risk Scale

A lower score indicates better sustainability

Negl

0-10

Low

10-20

Med

20-30

High

30-40

Severe

40+

Exposure

Exposure refers to the extent to which a company is exposed to different material ESG issues

Management

Management is related to actions taken to manage ESG issues

Peers Analysis

Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.

Global

Covered Companies

of 13,593

Rank

Percentile

Textiles & Apparel

Industry

of 160

Rank

Percentile

Footwear

Subindustry

of 32

Rank

Percentile

To view Dr. Martens’s complete esg history, request access »

Dr. Martens Affiliates

Subsidiaries (1)

Name Industry Location Year Founded
Dr Martens Airwair Wholesale Wollaston, United Kingdom 2021

Dr. Martens FAQs

  • When was Dr. Martens founded?

    Dr. Martens was founded in 1960.

  • Where is Dr. Martens headquartered?

    Dr. Martens is headquartered in London, United Kingdom.

  • What is the size of Dr. Martens?

    Dr. Martens has 2,377 total employees.

  • What industry is Dr. Martens in?

    Dr. Martens’s primary industry is Footwear.

  • Is Dr. Martens a private or public company?

    Dr. Martens is a Public company.

  • What is Dr. Martens’s stock symbol?

    The ticker symbol for Dr. Martens is DOCS.

  • What is the current stock price of Dr. Martens?

    As of 20-Nov-2026 the stock price of Dr. Martens is $0.68.

  • What is the current market cap of Dr. Martens?

    The current market capitalization of Dr. Martens is $649M.

  • What is Dr. Martens’s current revenue?

    The trailing twelve month revenue for Dr. Martens is $983M.

  • Who are Dr. Martens’s competitors?

    Salvatore Ferragamo and HBL Realisations are competitors of Dr. Martens.

  • What is Dr. Martens’s annual earnings per share (EPS)?

    Dr. Martens’s EPS for 12 months was $0.04.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process